Serum biomarkers of non-neuron-endocrine origin in small-cell lung cancer: a 16-year study on carcinoembryonic antigen, tissue polypeptide antigen and lactate dehydrogenase.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Lung Cancer

• Publication date

  2000-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0169-5002(00)00123-9PMID 11008008
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonparametric Statistics for the Behavioral Sciences

  2022cited by this paper
• Neuron-specific enolase, thymidine kinase, and tissue polypeptide-specific antigen in diagnosis and response to chemotherapy of small-cell lung cancer.

  1999cited by this paper
• TUMOR MARKERS : CLINICAL MEANING AND USE

  1999cited by this paper
• Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy

  1998cited by this paper
• Pretreatment serum lactate dehydrogenase as additional staging parameter in patients with small-cell lung carcinoma

  1998cited by this paper
• Revisions in the International System for Staging Lung Cancer.

  1997cited by this paper
• Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.

  1996cited by this paper
• Evaluation of Cyfra 21-1 as a marker for lung cancer.

  1996cited by this paper
• Anti-CEA immunoscintigraphy and computed tomographic scanning in the preoperative evaluation of mediastinal lymph nodes in lung cancer.

  1996cited by this paper
• Tumor markers. An update.

  1996cited by this paper
• Clinical applications of serum markers for lung cancer.

  1995cited by this paper
• Clinical Investigations: Tumors and PseudotumorsThe Tissue Polypeptide Antigen Serum Test in the Preoperative Evaluation of Non-Small Cell Lung Cancer: Diagnostic Yield and Comparison With Conventional Staging Methods

  1995cited by this paper
• Monitoring lung cancer with tissue polypeptide antigen: an ancillary, profitable serum test to evaluate treatment response and posttreatment disease status.

  1995cited by this paper
• Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.

  1994cited by this paper
• Serum tumour markers in lung cancer: history, biology and clinical applications.

  1994cited by this paper
• Comparison of Cyfra 21–1, Tpa and Tps in Lung Cancer, Urinary Bladder Cancer and Benign Diseases

  1994cited by this paper
• Cyfra 21–1 in Lung Cancer: Comparison with Cea, Ca 125, Scc and Nse Serum Levels

  1994cited by this paper
• Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.

  1993cited by this paper
• Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancer.

  1993cited by this paper
• Imaging lung cancer by scintigraphy with indium 111‐labeled F(ab')2 fragments of the anticarcinoembryonic antigen monoclonal antibody F023C5

  1992cited by this paper
• Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer.

  1991cited by this paper
• Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer.

  1991cited by this paper
• Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?

  1990cited by this paper
• Yield of Total Body GA-67 Scintigraphy in the Staging of Non-Small Cell Lung Cancer

  1989cited by this paper
• Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer.

  1989cited by this paper
• The release of chromogranin A and B like activity from human lung cancer cell lines. A potential marker for a subset of small cell lung cancer.

  1989cited by this paper
• Prognostic value of pretreatment carcinoembryonic antigen, neuron‐specific enolase, and creatine kinase‐BB levels in sera of patients with small cell lung cancer

  1988cited by this paper
• Usefulness of tissue polypeptide antigen in staging, monitoring, and prognosis of lung cancer.

  1988cited by this paper
• Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19‐9

  1987cited by this paper
• A new international staging system for lung cancer.

  1987cited by this paper
• Neuron-specific enolase as a guide to the treatment of small cell lung cancer.

  1987cited by this paper
• Use of carcinoembryonic antigen in small cell lung cancer prognostic value and relation to the clinical course 1

  1987cited by this paper
• The new International Staging System for Lung Cancer.

  1986cited by this paper
• Clinical value of a multiple biomarker assay in patients with bronchogenic carcinoma

  1986cited by this paper
• Elevated serum chromogranin A concentrations in small-cell lung carcinoma.

  1986cited by this paper
• Secretion of chromogranin A by peptide-producing endocrine neoplasms.

  1986cited by this paper
• Biological and clinical implication of neuron-specific enolase and creatine kinase BB in small cell lung cancer.

  1986cited by this paper
• Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung.

  1985cited by this paper
• Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer.

  1985cited by this paper
• Creatine kinase BB and beta-2-microglobulin as markers of CNS metastases in patients with small-cell lung cancer.

  1985cited by this paper
• Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancer.

  1985cited by this paper
• Elevated serum creatine kinase BB levels in patients with small cell lung cancer.

  1984cited by this paper
• Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.

  1984cited by this paper
• Topical Reviews in Radiotherapy and Oncology

  1983cited by this paper
• The meaning and use of the area under a receiver operating characteristic (ROC) curve.

  1982cited by this paper
• Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.

  1982cited by this paper
• International Histological Classification of Tumours

  1981cited by this paper
• Reporting results of cancer treatment

  1981cited by this paper
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

  1977cited by this paper
• Primer on certain elements of medical decision making.

  1975cited by this paper
• Predictive value of laboratory tests

  1975cited by this paper
• Letter: Predictive value of laboratory tests.

  1975cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• The clinical evaluation of chemotherapeutic agents in cancer

  1949cited by this paper
• Evaluation of chemotherapeutic agents

  1949cited by this paper

• Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?

  2017cites this paper
• Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis

  2015cites this paper
• Serum markers in small cell lung cancer: opportunities for improvement.

  2013cites this paper
• Elevated Serum C-Reactive Protein as a Prognostic Marker in Small Cell Lung Cancer

  2011cites this paper
• Tumorigenesis and Neoplastic Progression Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy

  2010cites this paper
• Dolor abdominal en una mujer de 57 años

  2008cites this paper
• [Abdominal pain in a 57-year-old woman].

  2008cites this paper
• Prognostic Factors for Small-Cell Lung Cancer

  2006cites this paper
• High serum YKL-40 level in patients with small cell lung cancer is related to early death.

  2004cites this paper
• Prognostic factors of small cell lung cancer.

  2004cites this paper
• Biomarkers in Drug Discovery and Development: From Target Identification through Drug Marketing

  2003cites this paper
• Identifying patients at risk of early postoperative recurrence of lung cancer: a new use of the old CEA test.

  2003cites this paper
• Anemia as an independent prognostic factor for survival in patients with cancer

  2002cites this paper
• Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma

  2002cites this paper
• Interdisciplinary Pathology - Demonstrated for Lung Pathology

  2001cites this paper
• Cytokeratin-derived markersof lung cancer

  2001cites this paper
• The Ovarian Tumor Index Predicts Risk for Malignancy

  2000cites this paper